Mqs Management LLC Bristol Myers Squibb CO Transaction History

Mqs Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $395,295 - $520,414	9,821 New	9,821 $407,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $23,221 - $27,710	-479 Reduced 3.42%	13,533 $694,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $274,514 - $306,949	4,742 Added 51.15%	14,012 $813,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $52,242 - $58,006	820 Added 9.7%	9,270 $592,000
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $122,154 - $138,551	-1,859 Reduced 18.03%	8,450 $585,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $705,960 - $835,956	10,309 New	10,309 $741,000
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $95,931 - $105,653	-1,321 Reduced 33.08%	2,672 $206,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $309,920 - $371,622	-5,041 Reduced 55.8%	3,993 $292,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $484,493 - $564,805	9,034 New	9,034 $563,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.